12:00 AM
 | 
May 10, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

DUSA regulatory update

The FDA's Dermatologic and Ophthalmic Drugs Advisory Committee will review on...

Read the full 35 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >